Further to the ASX Notice released on 14 November 2017, ASX now confirms as follows.

Telix Pharmaceuticals Limited (Company) was admitted to the Official List of ASX today, Wednesday, 15 November 2017.

Official quotation of the Company’s securities will commence at 12:00 pm AEDT on Wednesday, 15 November 2017 on a deferred settlement basis.  The Company has raised $50.05 million by the offer of 77,000,000 ordinary shares at $0.65 per share under a prospectus dated 16 October 2017.

What do I need to do by when?

For further details, please refer to the Company’s prospectus dated 16 October 2017.

Need more information?

For further details, please refer to the Company’s prospectus dated 16 October 2017.

Issued by

James Gerraty, Manager, Listings Compliance (Melbourne)

Contact information

James Gerraty
+61 (03)  9617 7842
info@asx.com.au

Disclaimer